BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23787819)

  • 21. β-adrenergic receptor mediation of stress-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: roles for β1 and β2 adrenergic receptors.
    Vranjkovic O; Hang S; Baker DA; Mantsch JR
    J Pharmacol Exp Ther; 2012 Aug; 342(2):541-51. PubMed ID: 22593095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
    Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
    J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.
    Tejeda HA; Chefer VI; Zapata A; Shippenberg TS
    Psychopharmacology (Berl); 2010 Jun; 210(2):231-40. PubMed ID: 20232058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
    Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
    Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms.
    Valdez GR; Platt DM; Rowlett JK; Rüedi-Bettschen D; Spealman RD
    J Pharmacol Exp Ther; 2007 Nov; 323(2):525-33. PubMed ID: 17702903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors.
    Yu XC; Li HY; Wang HX; Wong TM
    J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cocaine Seeking During Initial Abstinence Is Driven by Noradrenergic and Serotonergic Signaling in Hippocampus in a Sex-Dependent Manner.
    Kohtz AS; Aston-Jones G
    Neuropsychopharmacology; 2017 Jan; 42(2):408-418. PubMed ID: 27515792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the Alpha-1 Antagonist Prazosin on KOR Agonist-Induced Reinstatement of Alcohol Seeking.
    Funk D; Coen K; Tamadon S; Lê AD
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):724-734. PubMed ID: 31556948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
    Bruchas MR; Macey TA; Lowe JD; Chavkin C
    J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.
    Ehrich JM; Phillips PE; Chavkin C
    Neuropsychopharmacology; 2014 Dec; 39(13):3036-48. PubMed ID: 24971603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour.
    Aldrich JV; Senadheera SN; Ross NC; Reilley KA; Ganno ML; Eans SE; Murray TF; McLaughlin JP
    Br J Pharmacol; 2014 Jul; 171(13):3212-22. PubMed ID: 24588614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
    Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
    J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism.
    Ross NC; Reilley KJ; Murray TF; Aldrich JV; McLaughlin JP
    Br J Pharmacol; 2012 Feb; 165(4b):1097-108. PubMed ID: 21671905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress decreases serotonin tone in the nucleus accumbens in male mice to promote aversion and potentiate cocaine preference via decreased stimulation of 5-HT
    Fontaine HM; Silva PR; Neiswanger C; Tran R; Abraham AD; Land BB; Neumaier JF; Chavkin C
    Neuropsychopharmacology; 2022 Mar; 47(4):891-901. PubMed ID: 34564712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.
    Walker BM; Kissler JL
    Neuropsychopharmacology; 2013 Oct; 38(11):2278-85. PubMed ID: 23689673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.
    Aldrich JV; Patkar KA; McLaughlin JP
    Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18396-401. PubMed ID: 19841255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for kappa-, but not mu-opioid, receptor activation in acute food deprivation-induced reinstatement of heroin seeking in rats.
    Sedki F; Eigenmann K; Gelinas J; Schouela N; Courchesne S; Shalev U
    Addict Biol; 2015 May; 20(3):423-32. PubMed ID: 24725195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference.
    Suzuki T; Shiozaki Y; Masukawa Y; Misawa M; Nagase H
    Jpn J Pharmacol; 1992 Apr; 58(4):435-42. PubMed ID: 1328733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice.
    Anderson RI; Lopez MF; Griffin WC; Haun HL; Bloodgood DW; Pati D; Boyt KM; Kash TL; Becker HC
    Neuropsychopharmacology; 2019 May; 44(6):1084-1092. PubMed ID: 30555162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.